So would it be fair to say that we would get a double digit royalty on whatever ITF gets from supplying the 3 main distributers?
Lets say final product is X.
The 3 large distributers get possibly 0.8X.
ITF possibly gets 0.4x.
We get 10% of 0.4X, eg. 0.04X.
1/25th of the product sale price.
Very rough but someone can possibly put together something realistic and not rampant.
The CDC also claim 84% of BV sufferers report no symptoms, lets keep revenue estimates realistic.
So would it be fair to say that we would get a double digit...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55099 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 65000 | 1 |
View Market Depth
| Last trade - 11.15am 25/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable